Additive renoprotective effects of B2-kinin receptor blocker and PPAR-γ agonist in uninephrectomized db/db mice. (Q53250686)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21537328%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

title

Additive renoprotective effects of B2-kinin receptor blocker and PPAR-γ agonist in uninephrectomized db/db mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21537328%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21537328%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

author name string

Sydney C W Tang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21537328%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Loretta Y Y Chan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21537328%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Joseph C K Leung

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21537328%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Amy Shan Cheng

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21537328%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Kar Neng Lai

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21537328%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

publication date

2 May 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21537328%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

published in

Laboratory Investigation

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21537328%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

volume

91

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21537328%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21537328%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

page(s)

1351-1362

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21537328%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/labinvest.2011.81

30 January 2020

exact match

0 references

cites work

The kallikrein-kinin system in health and in diseases of the kidney

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.81

Bradykinin receptor ligands: therapeutic perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.81

Bradykinin and high glucose promote renal tubular inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.81

The steroid and thyroid hormone receptor superfamily

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.81

Activation of tubular epithelial cells in diabetic nephropathy and the role of the peroxisome proliferator-activated receptor-gamma agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.81

Renoprotection by rosiglitazone in accelerated type 2 diabetic nephropathy: Role of STAT1 inhibition and nephrin restoration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.81

Angiotensin converting enzyme inhibitor but not angiotensin receptor blockade or statin ameliorates murine adriamycin nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.81

Increased tissue kallikrein levels in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.81

Inhibition of IGF-I-induced Erk 1 and 2 activation and mitogenesis in mesangial cells by bradykinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.81

The role of bradykinin in the antifibrotic actions of perindoprilat on human mesangial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.81

Diabetic nephropathy is markedly enhanced in mice lacking the bradykinin B2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.81

Senescence-associated phenotypes in Akita diabetic mice are enhanced by absence of bradykinin B2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.81

Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.81

Kallikrein protects against microalbuminuria in experimental type I diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.81

Pharmacological blockade of B2-kinin receptor reduces renal protective effect of angiotensin-converting enzyme inhibition in db/db mice model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.81

Mechanisms through which bradykinin promotes glomerular injury in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.81

Synergism between prostaglandin E2 and isoproterenol in stimulating glucose oxidation in the heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.81

Vasoactive potential of the b(1) bradykinin receptor in normotension and hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.81

Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.81

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.81

Rosiglitazone decreases albuminuria in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.81

Targeted deletion of B2-kinin receptors protects against the development of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.81

7 January 2021

Renal Kallikrein and Hemodynamic Abnormalities of Diabetic Kidney

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.81

7 January 2021

Effects of aprotinin on the kallikrein-kinin system in type I diabetes (insulitis)

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.81

7 January 2021

Effects of B1 and B2 kinin receptor antagonists in diabetic mice

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.81

7 January 2021

Role of tissue kallikrein in the cardioprotective effects of ischemic and pharmacological preconditioning in myocardial ischemia.

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.2011.81

7 January 2021